Palatin Technologies
PTN
#10980
Rank
C$12.44 M
Marketcap
C$6.99
Share price
1.42%
Change (1 day)
N/A
Change (1 year)

Earnings for Palatin Technologies (PTN)

Earnings in 2026 (TTM): -C$8.46 Million

According to Palatin Technologies's latest financial reports the company's current earnings are C$12.88 Million. In 2025 the company made an earning of -C$13.45 Million, an increase over its 2024 earnings that were of -C$37.65 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Palatin Technologies from 1998 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$8.46 Million-37.13%
2025 -C$13.45 Million-64.29%
2024 -C$37.65 Million-16.9%
2023 -C$45.3 Million5.99%
2022 -C$42.74 Million-13.7%
2021 -C$49.53 Million33.25%
2020 -C$37.17 Million-172.11%
2019 C$51.53 M2352.33%
2018 C$2.1 M-94.13%
2017 C$35.81 M-154.92%
2016 -C$65.21 Million3.67%
2015 -C$62.9 Million878%
2014 -C$6.44 Million-72.64%
2013 -C$23.51 Million-33.11%
2012 -C$35.14 Million77.71%
2011 -C$19.78 Million
2003 -C$33.49 Million29.93%
2002 -C$25.77 Million36.18%
2001 -C$18.93 Million
1999 -C$15.71 Million6.04%
1998 -C$14.82 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$36.62 B-419,974.84%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$20.02 B-229,711.05%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
C$1.14 B-13,209.87%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-C$15.02 Million 72.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
C$0.34 B-4,011.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-C$0.17 Billion 1,784.89%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
C$0.19 B-2,384.53%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-C$41.21 Million 372.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-C$77.52 Million 788.76%๐Ÿ‡บ๐Ÿ‡ธ USA